CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm: Fritz et al. demonstrated that CEA > 5 μg/L was present in 40% of patients with invasive IPMN and only in the 8% with a non-invasive IPMN, showing a sensitivity of 40% and a specificity of 92.4% [22].